subject area of
- Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (amd) - interim (month 6) analysis of clinical safety and efficacy Academic Article
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration - twelve-month clinical outcomes Academic Article
- VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice Academic Article
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects Academic Article
- VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis Academic Article
- VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis Academic Article